Pfizer Says Its Vaccine Is Highly Effective in 5- to 11-Year-Olds

 92 total views,  1 views today

The companies reported that a lower dose of the vaccine had a 90.7 percent efficacy rate in preventing symptomatic Covid-19 in a clinical trial.

From: New York Times